Adding a special type of radiation to standard palliative radiation
Part of Cancer clinical trials.
This study tests whether adding a special type of radiation to standard palliative radiation helps reduce symptoms like pain, shortness of breath, or bleeding. It's for people with tumors that can't be removed and are large.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor (any type) that has spread or is in the main site, and it's bigger than 5 cm and can't be removed with surgery.
- You can do light activity or are up and about more than half of your waking hours (performance status 0-3).
- You expect to live at least 3 more months.
- You have a symptom like pain, trouble breathing, bleeding, or trouble swallowing that you rate as at least 5 out of 10, and it's related to your tumor.
- You are at least 15 years old.
- You can start radiation treatment within 60 days of signing up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a planned form of palliative radiation therapy treats certain solid cancers that have spread outside the brain to larger soft-tissue areas. It may help shrink tumors and relieve symptoms, but it also asks you to meet specific safety and treatment-timing rules.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This trial tests a single, high-dose radiation treatment (guided by MRI) for people whose cancer has spread to up to 3 spots outside the brain or spine. The goal is to shrink these tumors with one session, potentially helping you live longer or feel better with fewer side effects.
This trial tests higher doses of radiation therapy to relieve symptoms from larger tumors that cannot be cured. The goal is to improve symptom control and quality of life.
This Phase 2 study tests whether a stronger (higher-dose) radiation plan can better reduce pain from tumors that have spread to bone or other areas. It’s meant to help people live more comfortably by targeting painful spots while avoiding certain high-risk situations.
This Phase 2 study compares a one-time, high-dose radiation treatment (SBRT) with the usual, shorter-course palliative radiation. The goal is to see which approach better relieves symptoms from metastatic (spread) cancer.
Hear when a new Metastatic Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.